New study tracks Real-World treatment of rare kidney disease in china
NCT ID NCT06099236
First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times
Summary
This study observes 367 Chinese patients with atypical hemolytic uremic syndrome (aHUS), a rare condition that causes blood clots and kidney damage. Researchers will track how patients are treated in routine care and monitor their health for up to 12-24 months. The goal is to better understand the disease and current treatment patterns in China.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL HEMOLYTIC UREMIC SYNDROME(AHUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Research Site
Beijing, Beijing Municipality, China
-
Research Site
Chongqing, Sichuan, China
-
Research Site
Anhui, China
-
Research Site
Beijing, China
-
Research Site
Chongqing, China
-
Research Site
Fujian, China
-
Research Site
Guangdong, China
-
Research Site
Guangxi, China
-
Research Site
Guizhou, China
-
Research Site
Hainan, China
-
Research Site
Hebei, China
-
Research Site
Henan, China
-
Research Site
Hong Kong, China
-
Research Site
Hubei, China
-
Research Site
Hunan, China
-
Research Site
Jiangsu, China
-
Research Site
Jiangxi, China
-
Research Site
Liaoning, China
-
Research Site
Shaanxi, China
-
Research Site
Shandong, China
-
Research Site
Shanghai, China
-
Research Site
Shanxi, China
-
Research Site
Sichuan, China
-
Research Site
Tianjin, China
-
Research Site
Xinjiang, China
-
Research Site
Zhejiang, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.